Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,356.00
Bid: 12,390.00
Ask: 12,394.00
Change: 28.00 (0.23%)
Spread: 4.00 (0.032%)
Open: 12,364.00
High: 12,454.00
Low: 12,322.00
Prev. Close: 12,328.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-London's FTSE 100 drops to near one-month low as lockdown fears weigh

Thu, 28th Jan 2021 09:24

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* UK demands AstraZeneca to deliver ordered vaccines

* Car output falls to lowest level since 1984

* Prudential drops on demerger and equity raise plans

* FTSE 100 falls 0.6%, FTSE 250 adds 0.4%
(Updates to close)

By Shashank Nayar and Amal S

Jan 28 (Reuters) - The FTSE 100 hit a near one-month
low on Thursday as energy stocks tracked commodity prices lower
following virus and lockdown-led demand worries, while the
vaccine row between the European Union and AstraZeneca Plc
continued to weigh.

AstraZeneca was the second biggest drag on the FTSE
100 index as Britain demanded it must receive all the COVID-19
vaccines it had ordered, while the EU warned drug companies that
it would use all legal means or even block exports unless they
agreed to deliver shots as promised.

The blue-chip FTSE 100 index fell 0.6% with insurer
Prudential being the top drag after it said it would
separate its U.S. business Jackson through a demerger and may
raise $2.5 billion to $3 billion in new equity.

"It's a very speculative bubble of a market that has
definitely led to people suggesting for a pullback," said Keith
Temperton, an equity sales trader at Forte Securities.

"So, in my view, it's a long overdue pullback and nothing to
be alarmed about particularly, but rather just an expected
market reaction for London."

Higher virus cases and lockdowns led the UK to its biggest
rise in vacant shops in over two decades, while car output fell
to its lowest level since 1984.

The export-heavy FTSE 100 has recorded consistent monthly
gains since Novemeber, but recently lost steam as rising cases
and lockdowns led British households to cut expenses while the
proportion of workers on furlough rose to its highest since
July.

British airline easyJet gained 4.6% even as it warned that
its prospect had worsened for the January-March quarter.
London-listed shares of Hungarian airline Wizz Air
jumped 4.7% after it vowed to use the coronavirus crisis to grab
business from rivals including easyJet.

Miner Anglo American slipped 3.9% after it trimmed
its 2021 production outlook for diamonds, but it kept output
targets for most other metals unchanged.
(Reporting by Shashank Nayar in Bengaluru; editing by
Uttaresh.V and Richard Chang)

More News
4 Jul 2023 16:49

LONDON MARKET CLOSE: Tepid close after quiet day with US market closed

(Alliance News) - Stocks in London were largely higher on Tuesday, though the FTSE 100 slipped into the red amid weakness, while US markets were shut for the independence day holiday.

Read more
4 Jul 2023 12:08

LONDON MARKET MIDDAY: Stocks higher amid US holiday-thinned trade

(Alliance News) - Stock prices in London were higher at midday on Tuesday, with the absence of US markets and any major economic releases keeping trade muted.

Read more
4 Jul 2023 09:27

LONDON BROKER RATINGS: Dunelm, AstraZeneca and Persimmon cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Jul 2023 18:26

AstraZeneca shares fall as lung cancer results not as strong as hoped

(Alliance News) - AstraZeneca PLC on Monday saw shares fall, as test results suggested a new lung cancer drug may be less successful than hoped, despite being generally positive.

Read more
3 Jul 2023 17:24

FTSE 100 inches lower as healthcare drags; miners rise

AstraZeneca down as lung cancer drug trial lags expectations

*

Read more
3 Jul 2023 17:11

European shares end lower as healthcare declines outweigh miner gains

STOXX 600 snaps four-day winning streak

*

Read more
3 Jul 2023 17:05

LONDON MARKET CLOSE: Blue chips lose early shine as US treads water

(Alliance News) - London's FTSE 100 ran out of steam on Monday to close little changed, while New York markets made a muted start to an abbreviated session ahead of Independence Day.

Read more
3 Jul 2023 12:42

Will UK stocks fare better as tech rally fades?

STOXX 600 up 0.1%

*

Read more
3 Jul 2023 12:05

LONDON MARKET MIDDAY: Miners and oil majors lead FTSE 100 march

(Alliance News) - European equities went into Monday afternoon on the up, with the FTSE 100 outperforming as it was supported by its natural resources sector and oil majors.

Read more
3 Jul 2023 11:37

The most anticipated recession is also the most postponed

STOXX 600 up 0.2%

*

Read more
3 Jul 2023 11:23

AstraZeneca shares drop as lung cancer trial update lags expectations

July 3 (Reuters) - AstraZeneca said on Monday an experimental precision drug slowed progression of lung cancer in a late-stage trial, but the company's shares fell as much as 6% as analysts said the benefits may not be as pronounced as hoped.

Read more
3 Jul 2023 09:07

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York,

Read more
3 Jul 2023 08:42

TOP NEWS: AstraZeneca, Daiichi hail datopotamab lung cancer trial

(Alliance News) - AstraZeneca PLC and Tokyo-based partner Daiichi Sankyo Co Ltd on Monday announced that their investigational antibody drug conjugate Datopotamab deruxtecan showed positive results in an advanced non-small cell lung cancer trial.

Read more
3 Jul 2023 07:57

AstraZeneca reveals mixed interim findings in lung cancer trial

(Sharecast News) - AstraZeneca announced on Monday that datopotamab deruxtecan, or 'Dato-DXd', has shown promising results in a trial in patients with locally-advanced or metastatic non-small cell lung cancer (NSCLC) who had previously received at least one therapy.

Read more
28 Jun 2023 11:54

IN BRIEF: AstraZeneca invests USD400 million in reforestation

AstraZeneca PLC - Cambridge-based pharmaceutical company - Announces USD400 million investment in global AZ Forest programme, aiming to plant 50 million trees by the end of 2025 and 200 million trees by 2030. Projects are in Brazil, India, Vietnam, Ghana and Rwanda. The programme is focused on reforestation, biodiversity and community resilience and spans over 100,000 hectares worldwide.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.